NCT04461899View on ClinicalTrials.gov

Changes in Serum antimüllerian Hormone Levels in Patients 3 and 12 Months After Endometrioma Sclerotherapy

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

April 14, 2023

Study Completion Date

April 14, 2023

Conditions
Endometriosis Ovary
Interventions
BIOLOGICAL

Blood test

additional blood test will be done 3 and 12 months after endometrioma sclerotherapy.

Trial Locations (3)

69004

Hopital de la Croix Rousse, Lyon

69495

Hopital Lyon Sud, Pierre-Bénite

Unknown

Hopital Femme Mère Enfant, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04461899 - Changes in Serum antimüllerian Hormone Levels in Patients 3 and 12 Months After Endometrioma Sclerotherapy | Biotech Hunter | Biotech Hunter